Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
In 2019, the market size of Hadron Therapy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hadron Therapy.
This report studies the global market size of Hadron Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hadron Therapy production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Koninklijke Philips N.V.
Advanced Oncotherapy
Varian Medical Systems
Optivus Proton Therapy
Hitachi, Ltd.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Sumitomo Corporation
ProNova Solutions, LLC
Market Segment by Product Type
Electron Beam
Proton Beam
Neutron Beam
Carbon Ion Beam
Alpha Particle Beam
Beta Particle Beam
Market Segment by Application
Pediatric Cancer
Bone and Soft Tissue Cancer
Prostate Cancer
Lung Cancer
Liver Cancer
Eye Cancer
Head & Neck Cancer
Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Hadron Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hadron Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Hadron Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Hadron Therapy. Industry analysis & Market Report on Hadron Therapy is a syndicated market report, published as Global (United States, European Union and China) Hadron Therapy Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Hadron Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.